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CObjectives: : To quantify patients’ preferences for new pharmacist in-
dependent prescribing services in general practice for managing com-
mon existing long-term conditions compared with usual medical
prescribing. Methods: A discrete choice experiment cross-sectional
survey was conducted in five general practices in England (October–
November 2009). Four service attributes reported on the length of con-
sultation and aspects of patient-professional interaction. A choice be-
tween three alternatives—novel pharmacist independent prescribing
service (“prescribing pharmacist”), “own (family) doctor” service, and
“available (family) doctor” service—was presented. Alternative regres-
sion models were compared according to their goodness of fit, and the
preferred one was used to inform policy analysis. Results: A total of
51 patients completed questionnaires. Respondents preferred a
pharmacist” or “own doctor” compared with “available doctor,” with a
arger value given to own doctor. All attributes on patient-professional
nteraction were important in choosing how to manage diagnosed hy- O
nces
al So
oi:10.1016/j.jval.2012.02.006ertension, while the “length of consultation” (P  0.42) did not have
ny impact. The impact of introducing a pharmacist prescribing service
nto a general practice setting was estimated from these findings. Pa-
ients’ preferences suggested that about 16% of consultations with a
atient’s own doctor can be switched to a prescribing pharmacist in-
tead. Although there is a stronger preference for seeing own doctor,
lternative combinations of attribute levels can be used to compensate
nd reconfigure a more preferred prescribing pharmacist service.
onclusions: The pharmacist service is valued by patients as an alter-
ative to doctor prescribing in primary care and therefore represents
n acceptable form of service delivery when informing policy.
eywords: discrete choice experiment (DCE), NMP services, patient
references, pharmacist independent prescribing services, primary
are
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
In the United Kingdom, appropriately qualified pharmacists and
nurses prescribe independently, within their competence, any
medicine for any condition: for pharmacists, this excludes con-
trolled drugs. The introduction of independent prescribing across
the whole formulary in 2006 built upon previous forms of nonmed-
ical prescribing (NMP); “supplementary” prescribing was first in-
troduced in the United Kingdom in 2003 to enable pharmacists and
nurses to prescribe in partnership with an independent prescriber
(doctor or dentist) and within a patient-specific clinical manage-
ment plan [1]1. A supplementary prescriber is able to prescribe any
medicine, including controlled drugs, for any condition within his
or her competence. The scope of supplementary prescribing is an
issue that is agreed in the patient’s clinical management plan and
is for the medical judgment of the independent prescriber [2].
Health care professionals able to prescribe as supplementary pre-
scribers undertake a training program in prescribing and learning
practice with a medically qualified mentor. NMP policy aims to
* Address correspondence to: Karen Gerard, Faculty of Health Scie
oad, Highfield, Southampton, Hants SO17 1BJ, UK.
E-mail: K.M.Gerard@soton.ac.uk.
098-3015/$36.00 – see front matter Copyright © 2012, Internation
ublished by Elsevier Inc.improve patient care, choice and access, safety, use of health pro-
fessionals’ skills, and more flexible team working across the Na-
tional Health Service (NHS) [3,4]. It can further provide important
new opportunities to reconfigure the delivery of health care that
has a greater patient focus and a better use of scarce resources. For
example, the community pharmacist has been shown to provide
valued additional support for medication use, adherence, and re-
view [5].
In a patient-focused health service it follows that to take pa-
tients’ preferences into consideration we need their views on what
aspects of an extended professional role is valuable. We used the
discrete choice experiment (DCE) approach as the best valuation
tool for assessing patient preferences for the pharmacist indepen-
dent prescribing (PIP) service in the current study.
The DCE approach is a multiattribute-based survey method for
valuing benefits on a latent utility index. The approach assumes
individuals derived utility from the attributes of the service rather
than the service per se and choose from a set of alternatives the
one that gives highest utility. The DCE tool has been used to value
, University of Southampton, Nightingale Building (67), University
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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700 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 6 9 9 – 7 0 7a variety of patient experiences of health services [6], for example,
“quality of professional-patient relationship” and “continuity of
care.” The output from a DCE is versatile; it allows examination of
the important attributes of a service and discerning their impact
on choosing between alternatives. Results can inform decision
makers—for example, modeling the probability that particular
service configurations are taken up.
The DCE study reported forms part of a wider evaluation of
independent NMP in England [7]. The DCE identifies and quantifies
atient preferences for new PIP services in general practice for
anaging common existing long-term conditions. The study set
ut to address the following question: what are patients’ prefer-
nces for who prescribes their medication? It also aimed to quan-
ify the extent to which choosing who to consult is considered
mportant relative to other patient experience factors, explore
reference differences for prescribing services among key patient
ubgroups, and use the findings to predict the uptake of “prescrib-
ng pharmacist” services and assess the impact of quality im-
rovements to the service.
Methods
A DCE survey asks individuals to make hypothetical (yet realistic)
choices about their most preferred option from a choice of service
options uniquely described by combinations of attribute levels.
The approach is based on the premise that all decisions involve
choice and all choices involve sacrifice. Choosing forces the re-
spondent to value attributes against each other. Typically, respon-
dents are asked to complete a series of such choices. The under-
lying assumptions are that the individual can make informed
choices by weighing up the differences in attribute levels and will
consider all the information provided before selecting the alterna-
tive with the highest utility. A random utility model is used to
estimate the impact of attributes and contextual variables on
choice (preference) [8]. We used guidance on how to design a rig-
orous DCE to inform the development of this study [9].
The DCE questionnaire
Attributes and their levels
Four key attributes were selected to characterize differences in
consulting an NMP service (i.e., PIP) or a medical prescribing ser-
vice. The attribute levels were combined to describe unique alter-
natives important for patients yet amenable to change by the
service provider. Attribute selection was based on generic char-
acteristics known to be important to patients wanting better ac-
cess to family doctor services and a quality interpersonal relation-
ship where the professional is committed to the patient’s care
[10,11]. These generic attributes were tailored to represent the cur-
rent context: key differences in medical prescribing and NMP for a
long-term condition managed in general practice. Table 1 presents
Table 1 – Attributes and levels.
Attribute (short name) Levels
Length of consultation (length) 5, 10, 15, 20 (min)
Professional’s words and
explanations about your
medicines (words)
Difficult to understand Easy to
understand
Attention paid by professional
to your views about
medicines (attention)
Appears not to listen Appears
to listen
Health review covers (review) High blood pressure only High
blood pressure and review
of overall healthhe final list of attributes and levels used. Attribute levels weresufficiently varied to distinguish between alternatives by using
data from the national survey of prescribing pharmacists and the
pilot study.
The attribute reporting on access to prescribing services was
the “length of consultation.” Studies have shown the importance
of the length of a primary care consultation in patients’ experience
of satisfactory appointments [12], although the type of health
problem consulted for may mitigate this effect [11]. Typical doctor
appointments last between 5 and 10 minutes (although “double
appointments” can be booked [13]). In contrast, a national survey
of PIPs’ working practices showed consultations for a long-term
condition such as hypertension lasting, on average, 18 minutes
(range 5–60 minutes) [7]. The survey was distributed to all 358
pharmacists in England registered as an independent prescriber
on May 1, 2008 [7]. Longer PIP consultations, if they also enable
high-quality patient-professional interaction, may be an alterna-
tive option to support the development of frontline primary care
services.
Attributes reporting on patient-professional interaction were
“professional’s words and explanations about medication,” “at-
tention paid by the professional to the patient’s views about med-
icines,” and “the extent of review undertaken.”
Aside from the National Primary Care Research and Develop-
ment Centre’s own research [14], a substantial body of evidence
shows that the quality of patient-professional interaction matters
to patients, for example, “whether the doctor seemed to listen”
[15] and “doctor’s manner” [16]. In a survey of patient attitudes and
satisfaction with pharmacist supplementary prescribers and doc-
tors, value was attached to whether the professional knew the
patient well and/or demonstrated an interest in getting to know
them as “a whole person” rather than just their illness [17]. In a
study of pharmacists’ preferences for extending the community
pharmacy role, undertaking regular medication review was a sig-
nificant influence on choice [18] and further research has shown
that patients value pharmacist advice on all aspects of their med-
ication, general health, and lifestyle [5]. Pharmacists’ preferences
have also shown that they value providing patient-centered ser-
vices such as medication therapy management and chronic dis-
eases management [19]. The policymakers too believe that pro-
moting patient-centered care will improve patient adherence to
medication [20].
The choice context and the services on offer
We again drew on the PIP survey to ensure that respondents were
presented with an appropriate choice context in as realistic and
understandable way as possible. It showed that the most frequent
setting for prescribing was general medical practice (55% of active
pharmacists worked in this setting). Hypertension was the single
most common condition pharmacists managed (25% of the PIPs
reported this as the condition they prescribed most frequently
for). Overall, 77% of the survey respondents reported that they
worked from a diagnosis made by a doctor and 40% considered
that in their most common treatment area their prescribing re-
placed medical prescribing.
A “labeled”-choice experiment was selected for choosing be-
tween appointments for a prescribing pharmacist, “own (family)
doctor,” or “available (family) doctor” service. Such labels expect to
have an intrinsic value [21,22], and this has been demonstrated,
for example [23].
By focusing on an existing long-term condition managed by
either doctor or pharmacist (hypertension), we assumed prior di-
agnosis at the time of the current appointment and it followed that
the subsequent consultation was for managing and reviewing
medication, adherence, and providing a routine health checkup.
We assumed that patients wanted to attend follow-up appoint-
ments with a prescribing pharmacist, “own doctor,” or an “avail-
able doctor.” In any such appointment, the prescriber (“own” doc-
m701V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 6 9 9 – 7 0 7tor, “available” doctor, or prescribing pharmacist) would be
expected to check the patient’s blood pressure, review his or her
response to treatment (including any side effects etc.), and make
any necessary changes to treatment.
When making appointments to see a family doctor, patients
prefer to consult with someone they know and trust [24]. On this
basis, we hypothesized that an appointment with any available
doctor would be less preferred than with the patient’s own doctor
and used this as a fixed alternative least preferred choice.
To help respondents choose, we used a vignette that described
the purpose of the appointment (Fig. 1). This was based on the PIP
survey, expertise within the evaluation team, and the literature
[5,22–27].
Creating the choice set
Current design practice was followed to design the choice set (see
[6]). An online design catalog was used to derive an orthogonal
fractional factorial design (i.e., uncorrelated levels of attributes)
with 16 profiles (www.research.att.com/njas/oadir/). The second
choice was created by using a systematic-level change (a standard
approach in which design codes assigned to the attribute increase
by a constant factor to produce a uniquely different set of alterna-
tives [21]). Presenting a third choice (available family doctor)
Vignette:  Imagine you have had high blood 
is now time for your regular review at your ge
blood pressure being measured and may inv
Example of choice Prescribin
pharmacis
Length of consultation 20 min 
Professional's words & 
explanations about your 
medicines 
easy to 
understand
Attention paid by 
professional to your views 
about medicines 
appears to 
Health review covers 
only high b
pressure 
Which would you choose?  
Tick one box only 
Fig. 1 – Vignette aneant that statistical properties and statistical efficiency of thefinal design was checked following piloting and the identification
of attribute levels for this fixed option. The total number of choices
to individuals was minimized by blocking the experimental design
into four different questionnaire versions incorporating four
choices each (details of the experimental design are available
upon request).
Developing the DCE questionnaire for the survey
The pilot tested the feasibility of the DCE instrument with 12 pa-
tients attending a general practice (summer 2009) and collected
information on respondent’s own experience of primary care (to
inform levels for the fixed alternative available doctor). Respon-
dents evaluated the vignette and attributes as plausible and ques-
tionnaire length “about right” (on average 9 minutes to complete).
Respondents described a typical visit to see the available doctor
by using the attribute levels. This was seeing the doctor for a
10-minute consultation, the doctor used difficult to understand
words and explanations about medication, the doctor appeared
not to listen well to the patient’s views about medicines, and the
visit covered a limited health checkup.
The final survey instrument contained four consultation
choices per questionnaire version (and a fifth choice to check for
“consistency”) and background questions about the individual—
sure (hypertension) for some time and it 
l practice surgery.  This will involve your 
some changes to your medication.
Your own 
doctor 
Available 
doctor 
5 min 10 min 
difficult to 
understand 
difficult to 
understand 
n 
appears not to 
listen 
appears not to 
listen 
both high blood 
pressure & 
overall health  
only high blood 
pressure 
ample of a choice.pres
nera
olve 
g 
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702 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 6 9 9 – 7 0 7whether they pay for NHS prescriptions), health status (chronic
health problems, health today), use of prescriptions, expectations
(of getting a prescription), and experience of NMP services. An
example of a choice is given in Figure 1.
The Survey, Sample Size, and Ethics Approval
The survey was conducted during October and November 2009 in
five general practices geographically spread across England pro-
viding NMP services with health professionals working within
their premises. Three practices listed a total of two NMP personnel
within their staff, while two practices employed one PIP. Respon-
dents were current patients waiting to see health professionals in
the doctor surgery. Overall, each practice was asked to hand out
150 questionnaires. However, because each practice could not
keep close track of the 150, it was not possible to calculate a re-
sponse rate. Each practice had 38 questionnaires of each version,
with a minimum target response of 105 questionnaires (70%);
overall, the target was 525. This sample size provided ample op-
portunity to explore subgroup analysis and respondent heteroge-
neity, because sample size calculation was based on a minimum
100 responses per subgroup [28]. A priori two subgroups were of
articular interest—the impact of previous experience of an NMP
ervice and consistency of respondents. The importance of expe-
ience has previously been demonstrated [23]. DCEs rely on hypo-
thetical choices, and much debate has grown up around the issue
of whether to include all respondents or only those who have
answered consistently [6]. Because currently available tests of
onsistency are not conclusive, best practice is to explore the im-
act of consistency by considering utility models with/without
nconsistent respondents but remain cautious of deleting re-
ponses because this may be inappropriate for policy-making pur-
oses (see discussion on the matter reported by Lancsar and Lou-
iere [9]).
NHS Ethics approval was obtained from Dorset Research Ethics
ommittee in February 2009 (REC Ref No 08/H0201/163).
Utility models, their comparison, and theoretical validity of
responses
When analyzing responses to multiple-choice DCE survey, typ-
ically the multinomial logit (MNL) model is used, although there
is growing application of alternative models when relaxing its
assumptions. One example is provided by the mixed logit (MXL)
model, a framework already employed when evaluating health
care intervention [4]. Our strategy sought the most parsimoni-
ous model by starting with a basic MNL model to predict choice
by using all responses (MNL1) followed by an MNL specification
to allow for some predefined taste heterogeneity within respon-
dents (MNL2) and an unrestricted MXL. Two subgroups were
also examined separately by using the basic additive main ef-
fects MNL model: experienced in using NMP services (MNL3)
and “consistent” respondents (MNL4) (further details of the
MNL and MXL models used are available upon request). Empir-
ical models were analyzed by using BIOGEME software (http://
biogeme.epfl.ch/).
Modeling comparison was undertaken and any improve-
ment in model fit (i.e., MNL2 or MXL compared with MNL1) was
assessed by the relative increase in Pseudo R2 value and log
likelihood ratio test [22]. Given the differences in the sub-
samples used in MNL3 and MNL 4 models, it is not appropriate
to compare them.
The theoretical validity of responses was checked by testing
the sign of attribute coefficients. A priori we expected respondents
to prefer longer consultations (positive sign), easy to understand
words and explanations (positive sign), more attention paid to
patient’s views (positive sign), and more comprehensive review
(positive sign).Policy analysis
Results from the utility models can be used to estimate the prob-
ability of uptake for the introduction of a new (prescribing phar-
macist) service. This kind of information may be a useful contri-
bution to policy analysis. We use results from the preferred model
to estimate the impact of introducing the prescribing pharmacist
service into a general practice setting. In doing so, attribute levels
are predefined and resultant utility scores converted to probabili-
ties (for details, see Equation 1, Table 4, and [8]). We also used the
same utility functions to derive utility scores for given levels of
own doctor and new prescribing pharmacist services to assess the
impact of quality improvements to the service. In this scenario, we
considered that no additional resources were available to improve
a current own doctor service but that by considering trade-off in-
formation between attributes how a better service could be con-
figured by reducing one aspect of service (attribute level) for an
increase in another attribute level and how, overall, this could
increase utility. When using DCE findings to inform policy analy-
sis, the overall representativeness of the sample needs to be con-
sidered and any limitation discussed.
Results
Patients’ responses and their background characteristics
Questionnaires were completed from 451 patients attending all
practices. Response rates were not calculable. Table 2 shows the
Table 2 – Characteristics of sample and choices.
Characteristics (short name) n %
All respondents (N  451)
Sex (female) 217 51.9
Age (age), median (IQR) 48 (35–62)
Lives with a chronic disease (chronic) 181 40.3
Health today
Very good 50 11.2
Good 137 30.7
Neither good nor poor 118 26.5
Poor 121 27.1
Very poor 20 4.5
Usually pays for NHS prescription
(payNHS)
289 72.3
Income status
Up to £20,000 119 28.2
£21,000–£40,000 165 39.1
More than £40,000 138 32.7
Expecting a prescription today 250 56.1
Expecting to see pharmacist today 50 19.9
Has experience consulting
nonmedical prescriber
(experienced)
166 43.0
Passed consistency test* (consistent) 356 21.1
Observations (N  1779)
Choice
Prescribing pharmacist 761 42.8
Your own family doctor 984 55.3
Available family doctor 34 1.9
IQR, interquartile range; NHS, National Health Service.
* Consistent responses were identified by building in a test of “con-
sistency” into the questionnaire. A pseudo choice that contained
one superior option in a set of choices was added, i.e., dominated
on all the attribute levels—a “pass” was given for the dominant
option being selected.background characteristics of respondents and the distribution of
h
n
703V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 6 9 9 – 7 0 7choices across the alternatives. The age of the 451 patients sam-
pled ranged from 35 to 62 years, and the average income was in the
range of £21,000 to £40,000. Two hundred fifty patients (56.1%)
came to the surgery expecting to get a prescription, and 50 pa-
tients (19.9%) were expecting to see a prescribing pharmacist.
When asked whether they had previously seen a nonmedical pre-
scriber, 166 (43.0%) indicated that they had. By using a standard
test of consistency, we found that ninety-five respondents (21.1%)
“failed” to choose the alternative depicting “more of a good thing”
and could possibly be regarded as inconsistent.
When considering responses to the key question of patients’ pre-
ferred prescribing service, as predicted, the fixed alternative, “available
family doctor,” was chosen on very few occasions (2%). Rather patients’
choices were more evenly distributed between the more preferred al-
ternatives prescribing pharmacist (43%) and “own family doctor” (55%).
Utility models
All respondents: MNL1, MNL2, and MXL
Table 3 presents the regression results for all models run. The first
series of results relates to the basic model, MNL1, and is shown in
the third column of the table. Overall, this basic model, the most
largely applied, retained decent model fit (pseudo R2 of 0.406) [22].
The impact of attributes on choice shows. There is a general pref-
erence for managing preexisting hypertension by using a prescrib-
ing pharmacist (1 2.05; P 0.01) or own family doctor ( 2.41;
P  0.01)—these health professionals were more preferred to the
fixed alternative “available doctor.” This means that respondents
Table 3 – The regression results.
Utility models A
All
MNL1
All w
interac
MNL
Pharmacist Coefficient (1) 2.05† 1.
Own doctor Coefficient (2) 2.41† 1.
Length of consultation Coefficient (1) 0.005 0.
Professional’s words Coefficient (2) 0.686† 0.
Attention paid to patient’s
views
Coefficient (3) 0.889† 0.
Extent of review Coefficient (4) 0.173† 0.
Female (5) 0.
Female (9) 0.
Age (6) 0.
Age (10) 0.
Chronic (7) 0.
Chronic (11) 0.
PayNHS (8) 0.
PayNHS (12) 0.
Number of responses 1767 1767
Number of respondents 451 451
Log likelihood (0) 1940.437 1940.
Log likelihood (model) 1153.507 1131.
Psuedo R2 0.406 0.
Log likelihood ratio test 44.
Note. The preferred model MNL1 used for policy analysis is reported
MNL, multinomial logit; MXL, mixed logit; NHS, National Health Serv
* Estimated with normal distributions assigned to variables 1 to 4 b
† Statistically significant at the 1% level.preferred to move from a service provided by an available doctor toan alternative offering to see a prescribing pharmacist or own doc-
tor; however, this move was not equally preferred. The larger
value given to own doctor suggests that this alternative was the
more preferred.
Furthermore, all service attributes considered in the experi-
ment, with the exception of the length of consultation (1 
0.005; P  0.42), were important in choosing how to manage di-
agnosed hypertension and had signs as expected. The attribute
“attention paid by professional to the patient’s views about med-
icines” was judged the most important (with greatest absolute
value of 0.889; P   0.01), and respondents preferred profession-
als to appear to listen. Respondents were more likely to prefer a
service offering professional’s words and explanations about
medication that were easy to understand (positive value), profes-
sional appearing to listen to their views about medicines (“atten-
tion paid by professional to the patient’s views about medicines”
with positive value), and provide a comprehensive health care
review covering both issues of high blood pressure and overall
health (“the extent of review undertaken” with positive value).
Next, we turn to the impact of the alternative models MNL2
and MXL. MNL2 appears to have comparable goodness of fit to
MNL1; the pseudo R2 value increased to 0.410 and the log likeli-
ood ratio test comparing this model to MNL1 is statistically sig-
ificant (2  44.42, 8 degrees of freedom, and P  0.01). It also
informs some differences when taking account of individual
tastes. The fourth column of the table shows that in addition to the
same attributes bearing similar relative importance in the deci-
sion to choose, female respondents and those who live with a
pondents Subgroups
All
MXL*
Experienced in
using NMP
MNL3
“Consistent”
respondents
MNL4
Coefficient (1) 2.05† 2.13† 2.33
Coefficient (2) 2.42† 2.38† 2.35†
Mean (=1) 0.005 0.006 0.004
SD 0.000
Mean (=2) 0.693† 0.668† 0.824†
SD 0.005
Mean (=3) 0.906† 0.844† 1.020†
SD 0.262
Mean (=4) 0.171† 0.115 0.135†
SD 0.000
1767 653 1405
451 166 356
1954.43 716.583 1543.550
1159.76 432.939 856.736
0.401 0.387 0.441
12.506
lics bold.
MP, nonmedical prescribing.
g 100 Halton draws and convergence was achieved in 1000 iterations.ll res
ith
tions
2
13†
73†
004
695†
906†
173†
898†
466
000
000
930†
931†
222
222
437
297
410
42
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704 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 6 9 9 – 7 0 7consult. Female respondents more strongly prefer to choose a pre-
scribing pharmacist service (5  0.898; P  0.01) and those who
ive with a chronic health condition hold stronger (and equal) pref-
rences for seeing a prescribing pharmacist (7  0.930; P  0.01)
nd own family doctor (11  0.931; P  0.01) compared with the
verage respondent.
The MXL model results are shown in column 6 of the table. In
his case, the model does not appear to fit as well, the pseudo R2
value decreased to 0.401, and although overall there was a statis-
tically significant improvement in the log likelihood ratio test
compared with model MNL1 (2  12.506, 4 degrees of freedom,
and P  0.01), there was no added value in the information ob-
tained. The same general picture is true as it is for MNL1: a general
preference for managing preexisting hypertension by using a pre-
scribing pharmacist (1  2.05; P  0.01) or own doctor (2  2.42;
P  0.01) and the mean of the sample population random param-
ter estimates taking on similar importance. That is to say that the
ength of consultation was found not to be important (=1 
0.005; P  0.42) but the remaining attributes were. Their mean
stimates were statistically significant: “attention paid by profes-
ional to the patient’s views about medicines” was again judged
he most important (with greatest absolute value of 0.906; P 
0.01) followed by professionals appearing to listen (=2  0.693;
P  0.01) and “health care review” (=4  0.171; P  0.01). None of
he estimates for the spread around the mean values, however,
as statistically significant, suggesting that no further heteroge-
eity was identified.
Subgroups: Respondents experienced in using NMP and
consistent respondents
When considering the impact of experience of NMP on prefer-
ences (MNL3), the model appears to have an acceptable model fit
[22] (R2  0.387) even though two attributes “length of consulta-
tion” (10.004; P 0.83) and “extent of review” (4 0.173; P
0.32) are not valued (see Table 3).
The subgroup of respondents who were judged to have
passed the test of consistency (MNL4) also had a good model fit
(pseudo R2  0.441; see Table 3). Consistent respondents pre-
ferred, to similar extents, using a prescribing pharmacist ser-
vice (1  2.33; P  0.01) or own family doctor (  2.35; P  0.01)
ompared with the fixed alternative, “available doctor,” given
he similar absolute values on these coefficients. As with MNL1,
ho was seen was the main influence on choice with the re-
aining significant attributes contributing to preference in a
imilar (relative) order of importance.
Policy analysis
Output from the basic MNL1 was used for policy analysis. The
regression results can be used in a number of ways, including 1
predicting the impact of introducing a new service on the take up
of services (or market share) and 2 assessing the impact of quality
improvements to the service.
Predicting the impact of introducing a new service on the take
up of services
This is demonstrated in Table 4 where we assume two hypothet-
cal options currently available in a general practice for the ongo-
ng management of hypertension and then explore the impact of
ntroducing a new prescribing pharmacist service.
The existing services are described as 1 “basic” (or available
octor), where patients can see the available doctor for a 10-min-
te consultation during which they do not find the doctor appear-
ng to listen to their views about their medicines, or the doctor
sing easy to understand words and explanations about medica-
ion and performing a limited health review and 2 own doctor,
here patients can see their doctor for a 10-minute consultation eduring which they also find the doctor not appearing to listen to
their views about their medicines but the doctor uses easy to un-
derstand words and explanations about medication and performs
a comprehensive health review. The new prescribing pharmacist
service is similar to the own doctor option except that patients see
a prescribing pharmacist for a 10-minute consultation.
We use the MNL1 regression results to calculate the indirect
utility for each option and from that estimate the probability of
uptake (see Equation 1, as footnote to Table 4). Table 4 shows that
efore the introduction of the prescribing pharmacist service, the
wn doctor service makes up the predominant share of total con-
ultations, 96.3% compared with 3.6% for the basic option. After
he introduction of the new prescribing pharmacist service, the
tility model suggests a significant change in who is consulted.
bout 17% of consultations are switched from family doctor ser-
ices (either own doctor or available doctor) to prescribing phar-
acist services, the large majority (16%) from own doctor. This can
e seen as evidence of the acceptability of a prescribing pharma-
ist service to patients as a means of accessing their medicines
nd thus as a way of alleviating pressure on scarce doctor time.
Assessing the impact of quality improvements to the service
We further use the MNL1 regression results to estimate utility
scores obtained from given combinations of attribute levels and
overall preference for health professional consulted. From this we
can learn about the relative ranking of alternative service options
by overall utility and trade-offs between attributes that may in-
form how services can be reconfigured to yield greater patient
utility. Table 5 shows the estimated utility scores of a current level
of service (based on own doctor prescribing) and compares it with
a possible new prescribing pharmacist service. Although there is a
general stronger preference for seeing own doctor (1 2.41), this
s not the only factor contributing to utility. Thus, alternative com-
inations of attribute levels can be used to compensate for a given
wn doctor service. This is shown in the table by a prescribing
harmacist service that pays attention to the patients’ views
bout medicines when the own doctor service does not, all else
Table 4 – Probability of take up (based on MNL1).
Probability* of
choice
Option 1:
“Basic”
Option 2:
“Own doctor
service”
New option:
“Prescribing
pharmacist”
Before new prescribing
service
3.6% 96.3%
After new prescribing
service introduced
3.0% 79.5% 17.3%
MNL, multinomial logit.
* Probabilities calculated by using the following formula: Pc (option
1)  exp (V1n)/j exp Vjn (Equation 1), where individual n will
choose option 1 within a choice set C of J (j 1, ... , J) options. Note
results based on the attribute-level assumptions given as follows:
Option 1: 1  0, 2  0, 1 10 min, 2  difficult to understand
words and explanations, 3  doctor appears not to listen to pa-
tient’s views about medicines, 4  high blood pressure review;
Option 2: 1  0, 2  own doctor, 1 10 min, 2  easy to
understand words and explanations, 3  doctor appears not to
listen to patient’s views about medicines, 4  high blood pres-
sure review and review of overall health; Option 3: 1  prescrib-
ing pharmacist, 2  0, 1 10 min, 2  easy to understand
words and explanations, 3 doctor appears to listen to patient’s
views about medicines, 4  high blood pressure review and re-
view of overall health.qual. This combination of attribute levels is more preferred (the
705V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 6 9 9 – 7 0 7utility model predicts a utility of 3.793 compared with 3.264 for the
own doctor service described, a gain of 0.529 in overall utility).
Discussion
The wider study set out to evaluate NMP in England to inform
planning for current and future prescribers [7]. Part of this evalu-
ation included the DCE study reported, a study that investigated
and provided new empirical evidence of the strength of patient
preferences for using prescribing pharmacists in a primary care
setting. In health economics and health policy, it is important to
have such information on preferences and to use them in conjunc-
tion with efficient allocation of health care resources. By using the
estimated parameters from a well-fitting regression model, we
demonstrated not only patients’ acceptability of using prescribing
pharmacists for a certain condition but also explored how patients
trade between who they prefer to consult and other important
qualitative aspects of the service.
At the commencement of the study, there was limited infor-
mation of current working practices for the new prescribing phar-
macist role(s) or how these might be developed as frontline ser-
vices. Earlier evidence of supplementary prescribing pharmacist
showed then prescribing practices to be predominantly based in
primary care and for cardiovascular conditions [17]. Informed fur-
ther by the seminal national survey of pharmacists working prac-
tices [7], the decision was taken to elicit patient preferences within
a context of offering choice of family doctor (either own doctor or
available doctor) or prescribing pharmacist consultations. The
study assessed the relative importance of service attributes for
appointments to manage a preexisting condition, exemplified by
the cardiovascular condition hypertension. This choice context is
likely to remain relevant in the future development of frontline
services of this kind.
The study suggested that our sample found prescribing
pharmacist services plausible alternatives for family doctor ser-
vices. Depending on the model used to explain choices, all re-
spondents demonstrated the greatest preference for being seen
by their own doctor when compared with the available doctor
but also demonstrated a strong preference for being seen by the
prescribing pharmacist. This meant that there was evidence to
support a move from a service provided by an available doctor
to an alternative offering to see a prescribing pharmacist or own
doctor, all else being equal. Furthermore, the attribute “length
of consultation” was not on this occasion shown to be a statis-
tically significant predictor of choice. One explanation is that
follow-up consultations of long-term conditions such as hyper-
tension may simply not require longer consultations because
Table 5 – Utility scores for alternative service configuration
Factor New servic
Level
Alternative-specific constant PIP
Length of consultation 10 min
Professional=s words and
explanations about your
medicines
Easy to understand
Attention paid by
professional to your views
about medicines
Appears to listen
Health review covers Comprehensive
Total estimated utility
Gain in utility
MNL, multinomial logit; PIP, prescribing independent pharmacist.the patient is sufficiently knowledgeable about his or her con-dition and management; rather, it is the fine detail and quality
of service that matters. Therefore, what appeared to subse-
quently matter to the level of patients’ utility, and in order of
relative importance, were attributes reporting on patient-pro-
fessional interaction: “attention paid by the professional to the
patient’s views about medicines,” followed by “professional’s
words and explanations about medication,” and “the extent of
review undertaken.”
It was also observed that when key contextual variables were
explored as further determinants of choice, statistically significant
differences in tastes were limited to respondents’ gender and
health status. In our sample, it was female respondents who held
stronger preferences for choosing a prescribing pharmacist ser-
vice while those who live with a long-term health condition held
equally stronger preferences for a prescribing pharmacist service
and own doctor service when compared with the available doctor
service. As a result, one policy recommendation may be to provide
prescribing pharmacist services at locations and times at greatest
convenience to women and individuals with existing long-term
conditions. Findings from an RCT evaluating a community-phar-
macy–based medicines management service for chronic patients
with coronary heart disease showed females more satisfied with
the new pharmacy service [29].
While others have argued the importance of exploring the ex-
tent to which individuals may have different preferences and that
some of this may be unrelated to observable personal character-
istics [27], this study did not uncover any further preference het-
erogeneity of this kind, as evidenced by the lack of statistical sig-
nificance in the estimates for the SD values associated with
attributes in the MXL model that was estimated.
An interesting finding was the difference found between rela-
tive preferences obtained by the complete sample and a more lim-
ited sample judged to have answered the DCE consistently. Here
the main finding was that consistent respondents appeared to be
more equally balanced in their preference for a prescribing phar-
macist and family doctor than the whole sample. As previously
discussed, there is much debate in the literature about what to do
with such preferences. In the current study, the main impact of
our subgroup findings served to strengthen the relative impor-
tance of prescribing pharmacists.
When the results were used to explore the take up of new
prescribing pharmacist services under different states of the
world, our model showed that of the 17% of new prescribing phar-
macist consultations, most (16%) could expect to arise from a
switch from own family doctor services.
We further explored how the DCE could be used to exploit
“trade-off” information by considering whether patients might
sed on MNL1).
Current service
oefficient Level Coefficient
2.05 Own doctor 2.41
0.005 10 min 0.005
0.686 Easy to understand 0.686
0.889 Appears not to listen 0
0.173 Comprehensive 0.173
3.793 3.264
0.529s (ba
e
Cprefer to see a prescribing pharmacist if they were “compensated”
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706 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 6 9 9 – 7 0 7by particular changes in the level of other service attributes. In the
example given, we showed how an improvement in the attribute
“attention paid by professional to patients’ views about medica-
tion” yielded higher utility than the own family doctor service, all
else being equal.
Clearly, there are a number of strengths and weaknesses of an
empirical study such as this one. A particular strength was using
an evidence-based approach in planning the intervention, basing
the research on key findings from the health care literature and
previous DCE applications to pharmacy research as well as the
national survey in the first phase of the wide study. The choice set
for this study included an opt-out or status quo alternative with
ttribute levels defined during piloting work. This provided a fur-
her strength when limiting overestimation of responses [30]. In
he process of creating the experiment, contemporary issues
bout measuring design efficiency and choosing the most appro-
riate design available in terms of its statistical properties were
onsidered. A further strength of the DCE method is that alterna-
ive DCE modeling can be considered and a strategy for choosing
he preferred model developed [22]. In this case, a reasonably ex-
ensive strategy was adopted although there is always scope for
onsidering alternatives (e.g., different assumption in MXL models
r latent class models; see [19] for latent class model with appli-
ation to pharmacy). The impact of consistency of responses and
atient experience of NMP on regression modeling was also con-
idered. The implication of alternative models on policy decision
aking might also be a matter of discussion.
A possible limitation of the study was the representativeness
f the respondents and therefore generalizability of findings. Al-
hough the five sites involved in the study for data collection were
pread across England and delivered comparable NMP services [7],
he overall representativeness of the sample remains unknown
nd no other evaluation of NMP services in the United Kingdom
re available to compare findings. Poor patient responses from
hree specific general practice sites (i.e., fewer than 50 question-
aires per practice) could not allow testing for variability in patient
references across sites. Any possible issue in the representative-
ess of the sample could have an impact on policy analysis and
he use of findings to support any policy change.
The DCE survey involved a separate sample of patients from
he one replying to a wider patients’ experience questionnaire that
ook place within the wider study [7], but this two-phase survey
trategy did not reduce the number of patients who were available
o be given a DCE questionnaire. In both surveys we aimed at
istributing a questionnaire to comparable samples from each
articipating site (200 for the patients’ experience questionnaire
nd 150 for the DCE questionnaire). Unfortunately, data from the
wo surveys could not be linked and patients’ views and experi-
nces on their direct consultation with the independent prescrib-
rs could not be incorporated within the DCE modeling. A further
imitation to the study is that response rates were not calculable
ecause questionnaires handed out could not be tracked.
The experimental design used for this application was created
y adding a fixed opt-out option to a binary orthogonal choice set
erived from a catalog of orthogonal arrays with application of
oldover approach [21]. Alternative approaches are now available
o researchers to create multiple-choice designs that are statisti-
ally efficient [31]. Recent developments include using prior as-
umptions about parameters to improve statistical efficiency [32]
nd construct multiple-choice designs with customized reference
lternatives for each respondent (http://www.choice-metrics.
om).
Other aspects, such as possible concerns about the appropri-
teness of the health care received, might be important to patients
hen choosing between different health care packages, although
or our study the choice of these specific DCE attributes was sup-
orted by evidence from the literature, discussion with experts,nd pilot work with patients. Unfortunately, no costing data on the
elivery of the alternative services were considered. Future work
hould integrate costing and DCE output within a cost-effective-
ess framework to investigate how preferences (and their hetero-
eneity) might influence cost-effective decisions.
In conclusion our study demonstrates that patients have valid
references for how primary care prescribing services in general
ractice for long-term conditions are delivered. On this occasion,
he pharmacist prescribing service is valued by patients as an al-
ernative to doctor prescribing and therefore represents an accept-
ble form of service delivery when informing policy and practice.
n turn, it is important that policymakers and practices take note
f these preferences.
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